Bovie Medical Corporation Investing cash flow

Investing cash flow of APYX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Investing cash flow growth rates and interactive chart.


Highlights and Quick Summary

  • Investing cash flow for the quarter ending June 29, 2020 was $-94 Thousand (a 4.44% increase compared to previous quarter)
  • Year-over-year quarterly Investing cash flow decreased by -83.15%
  • Annual Investing cash flow for 2019 was $60.5 Million (a 106.62% increase from previous year)
  • Annual Investing cash flow for 2018 was $29.3 Million (a -4795.67% decrease from previous year)
  • Annual Investing cash flow for 2017 was $-624 Thousand (a 118.18% increase from previous year)
  • Twelve month Investing cash flow ending June 29, 2020 was $-967 Thousand (a -102.44% decrease compared to previous quarter)
  • Twelve month trailing Investing cash flow decreased by -101.77% year-over-year
Trailing Investing cash flow for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$-967 Thousand $39.6 Million $60.5 Million $54.6 Million
Visit stockrow.com/APYX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Investing cash flow of Bovie Medical Corporation

Most recent Investing cash flowof APYX including historical data for past 10 years.

Interactive Chart of Investing cash flow of Bovie Medical Corporation

Bovie Medical Corporation Investing cash flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.09 $-0.09
2019 $-0.23 $-0.56 $40.48 $20.84 $60.54
2018 $-6.16 $35.79 $-0.19 $-0.14 $29.3
2017 $-0.19 $-0.28 $-0.08 $-0.07 $-0.62
2016 $-0.1 $-0.14 $-0.02 $-0.02 $-0.29
2015 $-0.32 $-0.14 $-0.21 $-0.25 $-0.92
2014 $-0.31 $-0.16 $-0.09 $-0.08 $-0.63
2013 $-0.17 $-0.12 $-0.16 $-0.13 $-0.59
2012 $-0.3 $-0.16 $-0.04 $-0.24 $-0.75
2011 $-0.08 $-0.2 $-0.19 $-0.08 $-0.54
2010 $0.78 $-0.06 $-0.22 $-0.07 $0.43
2009 $-0.23 $-2.46

Business Profile of Bovie Medical Corporation

Sector: Medical
Industry: Med Prods
Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.